| Dr Kristy L Ritchie, MD | |
|
945 Bethesda Dr, Ste 330, Zanesville, OH 43701-0801 | |
| (740) 454-8800 | |
| (740) 454-7707 |
| Full Name | Dr Kristy L Ritchie |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 945 Bethesda Dr, Zanesville, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174709745 | NPI | - | NPPES |
| 9270902 | Other | OH | GROUP MEDICARE |
| 0989499 | Other | OH | GROUP MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35.087910 (Ohio) | Primary |
| 207V00000X | Obstetrics & Gynecology | 01064307A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Medical Group, Llc | 7719040385 | 218 |
News Archive
"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
40 years ago, Prof. Dr. Wolfgang Wiltschko was the first to prove that migrating robins use the Earth's magnetic field to direct themselves during migration.
Connecticut is a national leader in addressing the dental health needs of its children, according to a report released by the Pew Center on the States. The Cost of Delay: State Dental Policies Fail One in Five Children, released with support from the W.K. Kellogg Foundation and the DentaQuest Foundation, grades each state's policy responses to the urgent challenges in dental health among America's children.
Tethys Bioscience, a privately held company, announced today that it has closed a $25 million Series D round of financing led by aeris CAPITAL AG and including Wasatch Advisors as a new investor. All current investors, including MDV-Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital participated in the round. Tethys also announced that it has appointed George Rehm, Managing Partner of aeris CAPITAL, to the Tethys Board of Directors.
› Verified 1 days ago
| Entity Name | Genesis Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063663433 PECOS PAC ID: 7719040385 Enrollment ID: O20090107000547 |
News Archive
"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
40 years ago, Prof. Dr. Wolfgang Wiltschko was the first to prove that migrating robins use the Earth's magnetic field to direct themselves during migration.
Connecticut is a national leader in addressing the dental health needs of its children, according to a report released by the Pew Center on the States. The Cost of Delay: State Dental Policies Fail One in Five Children, released with support from the W.K. Kellogg Foundation and the DentaQuest Foundation, grades each state's policy responses to the urgent challenges in dental health among America's children.
Tethys Bioscience, a privately held company, announced today that it has closed a $25 million Series D round of financing led by aeris CAPITAL AG and including Wasatch Advisors as a new investor. All current investors, including MDV-Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital participated in the round. Tethys also announced that it has appointed George Rehm, Managing Partner of aeris CAPITAL, to the Tethys Board of Directors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristy L Ritchie, MD 945 Bethesda Drive, Suite 200, Zanesville, OH 43701-1880 Ph: (740) 454-4788 | Dr Kristy L Ritchie, MD 945 Bethesda Dr, Ste 330, Zanesville, OH 43701-0801 Ph: (740) 454-8800 |
News Archive
"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.
40 years ago, Prof. Dr. Wolfgang Wiltschko was the first to prove that migrating robins use the Earth's magnetic field to direct themselves during migration.
Connecticut is a national leader in addressing the dental health needs of its children, according to a report released by the Pew Center on the States. The Cost of Delay: State Dental Policies Fail One in Five Children, released with support from the W.K. Kellogg Foundation and the DentaQuest Foundation, grades each state's policy responses to the urgent challenges in dental health among America's children.
Tethys Bioscience, a privately held company, announced today that it has closed a $25 million Series D round of financing led by aeris CAPITAL AG and including Wasatch Advisors as a new investor. All current investors, including MDV-Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital participated in the round. Tethys also announced that it has appointed George Rehm, Managing Partner of aeris CAPITAL, to the Tethys Board of Directors.
› Verified 1 days ago
Dr. Jessica Martin Lafyatis, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Mitesh H. Parekh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1210 Ashland Ave, Zanesville, OH 43701 Phone: 740-454-8551 | |
Dr. Callie Elyse Crider, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr Ste 330, Zanesville, OH 43701 Phone: 750-454-8800 | |
Dr. Linda T Swan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
Dr. Kristina L Loomis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Drive, Suite 330, Zanesville, OH 43701 Phone: 740-454-8800 Fax: 740-454-7707 | |
John M Lepi, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 945 Bethesda Dr, Suite 120, Zanesville, OH 43701 Phone: 740-452-6778 Fax: 740-454-4770 |